Cooper Companies Inc (COO) Shares Bought by KBC Group NV

KBC Group NV boosted its position in Cooper Companies Inc (NYSE:COO) by 35.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,007 shares of the medical device company’s stock after acquiring an additional 1,559 shares during the quarter. KBC Group NV’s holdings in Cooper Companies were worth $1,424,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Advisory Services Network LLC boosted its holdings in shares of Cooper Companies by 30.6% during the second quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock worth $109,000 after purchasing an additional 107 shares during the period. YorkBridge Wealth Partners LLC lifted its holdings in shares of Cooper Companies by 2.1% during the second quarter. YorkBridge Wealth Partners LLC now owns 531 shares of the medical device company’s stock valued at $126,000 after purchasing an additional 11 shares during the last quarter. Acrospire Investment Management LLC lifted its holdings in shares of Cooper Companies by 50.0% during the second quarter. Acrospire Investment Management LLC now owns 600 shares of the medical device company’s stock valued at $144,000 after purchasing an additional 200 shares during the last quarter. Canada Pension Plan Investment Board purchased a new position in shares of Cooper Companies during the third quarter valued at approximately $163,000. Finally, Penserra Capital Management LLC lifted its holdings in shares of Cooper Companies by 13.0% during the second quarter. Penserra Capital Management LLC now owns 884 shares of the medical device company’s stock valued at $211,000 after purchasing an additional 102 shares during the last quarter. 96.79% of the stock is currently owned by institutional investors and hedge funds.

Shares of Cooper Companies Inc (COO) opened at $229.66 on Wednesday. The company has a market cap of $11,182.45, a price-to-earnings ratio of 23.50, a P/E/G ratio of 1.85 and a beta of 0.54. The company has a current ratio of 2.41, a quick ratio of 1.26 and a debt-to-equity ratio of 0.36. Cooper Companies Inc has a 52-week low of $172.83 and a 52-week high of $256.39.

Cooper Companies (NYSE:COO) last posted its quarterly earnings data on Thursday, December 7th. The medical device company reported $2.65 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.64 by $0.01. The business had revenue of $561.50 million for the quarter, compared to the consensus estimate of $558.86 million. Cooper Companies had a net margin of 17.43% and a return on equity of 16.02%. The company’s revenue was up 8.3% compared to the same quarter last year. During the same period last year, the firm posted $2.28 earnings per share. equities analysts expect that Cooper Companies Inc will post 11.51 EPS for the current year.

Several equities research analysts recently weighed in on the stock. Oppenheimer set a $250.00 price target on shares of Cooper Companies and gave the company a “hold” rating in a research report on Friday, December 8th. Stifel Nicolaus reiterated a “buy” rating and set a $265.00 price target (down previously from $275.00) on shares of Cooper Companies in a research note on Friday, December 8th. Raymond James Financial restated a “buy” rating and set a $265.00 target price on shares of Cooper Companies in a research note on Monday, December 4th. Zacks Investment Research upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating and set a $257.00 target price on the stock in a research note on Tuesday, November 14th. Finally, KeyCorp reiterated a “hold” rating on shares of Cooper Companies in a research note on Friday, October 20th. Six research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $259.70.

In other Cooper Companies news, Director Gary S. Petersmeyer sold 3,977 shares of Cooper Companies stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $244.94, for a total transaction of $974,126.38. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.60% of the stock is owned by insiders.

COPYRIGHT VIOLATION NOTICE: “Cooper Companies Inc (COO) Shares Bought by KBC Group NV” was first reported by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this piece of content on another domain, it was stolen and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://stocknewstimes.com/2017/12/13/cooper-companies-inc-coo-shares-bought-by-kbc-group-nv.html.

About Cooper Companies

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply